Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2014

01-04-2014 | Breast Oncology

Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?

Authors: M. Griepsma, MSc, D. B. W. de Roy van Zuidewijn, MD, PhD, A. J. K. Grond, MD, PhD, S. Siesling, PhD, H. Groen, MD, PhD, G. H. de Bock

Published in: Annals of Surgical Oncology | Issue 4/2014

Login to get access

Abstract

Background

Residual breast tissue after a mastectomy can lead to a (second) primary breast cancer. The development of breast cancer after prophylactic mastectomy and the finding of normal breast tissue around a local recurrence support this assumption. The aim of the present study was to investigate the prevalence and localization of residual breast tissue after a mastectomy.

Methods

A series of 206 women who underwent a mastectomy between January 2008 and August 2009 in 11 hospitals were enrolled onto this study after written informed consent was obtained. From each mastectomy specimen, a total of 36 samples were obtained from the superficial dissection plane at predetermined locations. The biopsy samples were analyzed for the presence of benign breast tissue in the inked superficial area. Differences in percentage of positive samples were analyzed by generalized estimating equations to account for their interdependence.

Results

A total of 7,374 biopsy samples from 206 breast specimens of 206 patients were included in the analysis. In 76.2 % of the specimens (n = 157), one or more positive biopsy samples were found. The positive findings were found diffusely across the superficial dissection surface of the specimen with a significant predilection for the lower outer quadrant and the middle circle of the superficial dissection plane.

Conclusions

After a mastectomy, there is a high probability of residual breast tissue. This tissue is predominantly located in the middle circle of the superficial dissection plane and in the lower outer quadrant. Surgeons should be aware of these locations so they may remove as much of the benign breast tissue as possible.
Literature
1.
2.
Willemsen HW, Kaas R, Peterse JH, Rutgers EJ. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol. 1998;24:331–2.PubMedCrossRef
3.
Goodnight JE Jr, Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol. 1984;26:190–201.CrossRef
4.
Eldar S, Meguid MM. Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg. 1984;148:692–3.PubMedCrossRef
5.
Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg. 1989;13:15–21.PubMedCrossRef
6.
Ziegler LD, Kroll SS. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991;14:451–4.PubMed
7.
Lostumbo L, Carbine N, Wallace l. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.
8.
Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.PubMedCrossRef
9.
Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159–64.PubMedCrossRef
10.
Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055–62.PubMedCrossRef
11.
Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experience at the Rotterdam Family Cancer Clinic. Ann Surg Oncol. 2007;14:3335–44.PubMedCentralPubMedCrossRef
12.
Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.PubMedCrossRef
13.
Cao D, Tsangaris TN, Kouprina N, et al. The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling. Ann Surg Oncol. 2008;15:1330–40.PubMedCentralPubMedCrossRef
14.
Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non–skin sparing mastectomies. Ann Surg Oncol. 1999;6:676–81.PubMedCrossRef
15.
Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12.PubMedCrossRef
16.
Kroll SS, Khoo A, Singletary SE, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg. 1999;104:421–5.PubMedCrossRef
17.
Medina-Franco H, Vasconez LO, Fix RJ, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg. 2002;235:814–9.PubMedCentralPubMedCrossRef
18.
Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998;5:620–6.PubMedCrossRef
19.
Patani N, Mokbel K. Oncological and aesthetic considerations of skin-sparing mastectomy. Breast Cancer Res Treat. 2008;111:391–403.PubMedCrossRef
20.
21.
Singletary SE, Kroll SS. Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;30:39–52.PubMed
22.
Rivadeneira DE, Simmons RM, Fish SK, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J. 2000;6:331–5.PubMed
23.
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.PubMedCrossRef
24.
Vaughan A, Dietz JR, Aft A, et al. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate reconstruction. Am J Surg. 2007;194:438–43.PubMedCrossRef
25.
Kim JH, Tavassoli F, Haffty BG. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature. Cancer J. 2006;12:92–101.PubMed
26.
Hicken NF. Mastectomy. Clinical pathologic study demonstrating why most mastectomies result in incomplete removal of the mammary gland. Arch Surg. 1940;40:6–14.CrossRef
27.
Goldman LD, Goldwyn RM. Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg. 1973;51:501–5.PubMedCrossRef
28.
Temple WJ. Lindsay RL, Magi E, Urbanski SJ. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg. 1991;161:413–5.PubMedCrossRef
29.
Barton FE Jr, English JM, Kingsley WB, Fietz M. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg. 1991;88:389–92.PubMedCrossRef
30.
Tewari M, Kumar K, Kumar M, Shukla HS. Residual breast tissue in the skin flaps after Patey mastectomy. Indian J Med Res. 2004;119:195–7.PubMed
31.
Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44.PubMedCrossRef
32.
Beer GM, Varga Z, Budi S, Seifert B, Meyer VE. Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer. 2002;94:1619–25.PubMedCrossRef
33.
de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organization for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351–6.PubMedCrossRef
Metadata
Title
Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?
Authors
M. Griepsma, MSc
D. B. W. de Roy van Zuidewijn, MD, PhD
A. J. K. Grond, MD, PhD
S. Siesling, PhD
H. Groen, MD, PhD
G. H. de Bock
Publication date
01-04-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 4/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3383-x

Other articles of this Issue 4/2014

Annals of Surgical Oncology 4/2014 Go to the issue

Breast Oncology

Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

Hepatobiliary Tumors

Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome

Gastrointestinal Oncology

Outcome Data of Patients with Peritoneal Carcinomatosis from Gastric Origin Treated by a Strategy of Bidirectional Chemotherapy Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Single Specialized Center in Japan

Translational Research and Biomarkers

Fluorescence-guided Surgery with a Fluorophore-conjugated Antibody to Carcinoembryonic Antigen (CEA), that Highlights the Tumor, Improves Surgical Resection and Increases Survival in Orthotopic Mouse Models of Human Pancreatic Cancer

Colorectal Cancer

Analysis of Bevacizumab-based Preoperative Radiochemotherapy in Patients with Locally Advanced Rectal Cancer on Surgery-associated Spectrum of Complications

Gastrointestinal Oncology

Is Atypical Metastasis Obstructive to Sentinel Node Navigation Surgery in Early Gastric Cancer Patients?